Management of Parkinson's disease in older women.
Elderly women with Parkinson's disease (PD) represent a specific patient population that may benefit from individualized treatment strategies. PD has been shown to occur approximately twice as often in men than in women, resulting in theories regarding estrogen being protective against the disease and as a potential treatment strategy. Given women's longer life expectancy, they are more likely to reach an age where antiparkinsonian medications are associated with side-effects. This paper will review medical and surgical treatments as well as the relationship of gender and age with respect to the management of PD.
Price
Molly Daymont
MD
Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Shulman
Lisa M
LM
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D046690:Deep Brain Stimulation; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000453:epidemiology / Q000628:therapy*; D017678:Sex Distribution
D000978:Antiparkinson Agents